Interestingly, Manzano and colleagues investigated the degree of platelet desialylation to therapy response in ITP and observed that NR-ITP patients have lower levels of platelet GP sialic acid compared to healthy controls and to patients treated with TPO-RA [54]. The gene discussed is TPO; the disease is autoimmune thrombocytopenic purpura.